Abstract
Alternative hemodialysis (HD) schedules, including short-daily and nocturnal HD, continue to proliferate, with the hope of offering improved patient outcomes. Three nights per week and every other night, nocturnal HD are now being provided to more patients worldwide, both at home and in-center. However, alternative HD schedules are still experimental in most centers, and studies establishing the efficacy of these therapies with respect to major clinical outcomes are needed. Endorsed by the National Institutes of Health, the International Quotidian Dialysis Registry is an international collaboration that was established in 2002 to prospectively study large numbers of patients treated with alternate HD schedules. The Registry will ultimately allow alternate HD modalities to be compared to conventional thrice-weekly HD with respect to clinical endpoints, including mortality, using a prospective cohort study. To date, the Registry has enrolled 182, 1193, and 740 subjects from Canada, the United States, and Australia, respectively. This report is the fourth annual update and describes recruitment progress, baseline characteristics of enrolled patients, and worldwide prescription patterns.
| Language | English |
|---|---|
| Pages | 281-289 |
| Number of pages | 9 |
| Journal | Hemodialysis International |
| Volume | 12 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1 Jul 2008 |
Keywords
- Daily dialysis
- Dialysis outcomes
- Nocturnal dialysis
- Quotidian hemodialysis
- Registry
ASJC Scopus subject areas
- Hematology
- Nephrology
Cite this
}
The international quotidian dialysis registry : Annual report 2008. / Nesrallah, Gihad E.; Suri, Rita S.; Moist, Louise M.; Ofsthun, Norma J.; Hakim, Raymond; Mcdonald, Stephen P.; Marshall, Mark R.; Carter, Shannon T.; Lindsay, Robert M.
In: Hemodialysis International, Vol. 12, No. 3, 01.07.2008, p. 281-289.Research output: Contribution to journal › Article
TY - JOUR
T1 - The international quotidian dialysis registry
T2 - Hemodialysis International
AU - Nesrallah, Gihad E.
AU - Suri, Rita S.
AU - Moist, Louise M.
AU - Ofsthun, Norma J.
AU - Hakim, Raymond
AU - Mcdonald, Stephen P.
AU - Marshall, Mark R.
AU - Carter, Shannon T.
AU - Lindsay, Robert M.
PY - 2008/7/1
Y1 - 2008/7/1
N2 - Alternative hemodialysis (HD) schedules, including short-daily and nocturnal HD, continue to proliferate, with the hope of offering improved patient outcomes. Three nights per week and every other night, nocturnal HD are now being provided to more patients worldwide, both at home and in-center. However, alternative HD schedules are still experimental in most centers, and studies establishing the efficacy of these therapies with respect to major clinical outcomes are needed. Endorsed by the National Institutes of Health, the International Quotidian Dialysis Registry is an international collaboration that was established in 2002 to prospectively study large numbers of patients treated with alternate HD schedules. The Registry will ultimately allow alternate HD modalities to be compared to conventional thrice-weekly HD with respect to clinical endpoints, including mortality, using a prospective cohort study. To date, the Registry has enrolled 182, 1193, and 740 subjects from Canada, the United States, and Australia, respectively. This report is the fourth annual update and describes recruitment progress, baseline characteristics of enrolled patients, and worldwide prescription patterns.
AB - Alternative hemodialysis (HD) schedules, including short-daily and nocturnal HD, continue to proliferate, with the hope of offering improved patient outcomes. Three nights per week and every other night, nocturnal HD are now being provided to more patients worldwide, both at home and in-center. However, alternative HD schedules are still experimental in most centers, and studies establishing the efficacy of these therapies with respect to major clinical outcomes are needed. Endorsed by the National Institutes of Health, the International Quotidian Dialysis Registry is an international collaboration that was established in 2002 to prospectively study large numbers of patients treated with alternate HD schedules. The Registry will ultimately allow alternate HD modalities to be compared to conventional thrice-weekly HD with respect to clinical endpoints, including mortality, using a prospective cohort study. To date, the Registry has enrolled 182, 1193, and 740 subjects from Canada, the United States, and Australia, respectively. This report is the fourth annual update and describes recruitment progress, baseline characteristics of enrolled patients, and worldwide prescription patterns.
KW - Daily dialysis
KW - Dialysis outcomes
KW - Nocturnal dialysis
KW - Quotidian hemodialysis
KW - Registry
UR - http://www.scopus.com/inward/record.url?scp=55949088718&partnerID=8YFLogxK
U2 - 10.1111/j.1542-4758.2008.00268.x
DO - 10.1111/j.1542-4758.2008.00268.x
M3 - Article
VL - 12
SP - 281
EP - 289
JO - Hemodialysis International
JF - Hemodialysis International
SN - 1492-7535
IS - 3
ER -